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Samples of lung tissue, taken at time of lung transplant, from 13 Dutch Caucasian patients
with idiopathic pulmonary arterial hypertension (iPAH) and 14 patients with non-idiopathic
PAH were studied for the presence of human herpes virus-8 (HHV-8). By immunohisto-
chemical staining, in none of patients expression of HHV-8 latency-associated nuclear
antigen 1 (LANA-1) was demonstrated. Using two nested polymerase chain reactions (PCR)
to amplify part of the open reading frame (ORF) 65 and ORF 73, we failed to detect HHV-8
DNA in all samples studied. These results argue strongly against a role for HHV-8 in the
pathogenesis of iPAH.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Human herpes virus-8 (HHV-8), also known as kaposi’s
sarcoma (KS)-associated herpesvirus, is a vasculotropic virusElsevier Ltd. All rights reserved.
669111; fax: +31 20 6917584.
.nl (P. Bresser).that plays an etiological role in Kaposi sarcoma, primary
effusion lymphoma and multicentric Castleman disease.1 In
the past, HHV-8 has also been tentatively linked to various
other malignant and non-malignant diseases. The etiological
relationship between HHV-8 and these disorders, however,
has been clearly disproved by additional analysis after
the initial positive reports. Recently, HHV-8 infection was
reported to be associated with idiopathic pulmonary arterial
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HHV-8 in pulmonary arterial hypertension 855hypertension (iPAH).2 Idiopathic PAH is a rare, but fatal
disease, clinically characterized by progressive pulmonary
hypertension and right heart failure. Histopathologically,
the disease is characterized by an arteriopathy of the
small precapillary arterioles with proliferation of endothe-
lial cells and smooth muscle cells. Over time, these
conditions induce luminal obstruction, resulting in a gradual
increase in pulmonary vascular resistance. Moreover,
generally, in more advanced stages characteristic complex
vascular (plexiform) lesions can be observed. The etiology
of these lesions as well as the observed arteriopathy is far
from understood yet. Cool and coworkers2 reported the
presence of HHV-8 DNA and the expression of the HHV-8
latency-associated nuclear antigen 1 (LANA-1) in lung tissue
from 10 out of 16 iPAH patients. Surprisingly, LANA-1
expression was described not to be confined to cells within
plexiform lesions, but was also described to be present in
bronchoepithelial cells, inflammatory cells, and endothelial
cells lining patent vessels. Since, however, in studies in
German,3 French4 and Northern-American5 populations,
serologically, the incidence of HHV-8 infection did not
differ between iPAH patients and controls, these findings
were questioned. It was argued, however, that serologic
tests might fail to detect organ-specific HHV-8 infection.6
Subsequently, however, two Japanese groups were unable to
detect HHV-8 DNA in lung samples of Japanese iPAH
patients.7,8 Since these studies were performed in
Asian populations, it was argued that the pathogenesis of
iPAH may differ between patients with different ethnic
background.
In the present study, we investigated the expression of
LANA-1 and the presence of HHV-8 DNA in lung biopsies of
Dutch Caucasian patients with iPAH (n ¼ 13) and non-
idiopathic PAH (n ¼ 14) who underwent a lung transplant
at the University Medical Center Groningen.Subjects, materials and methods
Lung biopsy specimens were obtained at lung transplant
in all patients between 1991 and 2003. All patients
had a Caucasian ethnic background. Diagnoses were
revised according to international guidelines prior to the
study. Thirteen patients with iPAH (4074 yr) and 14 patients
with non-idiopathic PAH (3873 yr) were included in
the study.
Immunohistochemical staining was performed to identify
LANA-1 of HHV-8 encoded by the open reading frame 73
(ORF 73). Briefly, formalin-fixed, paraffin embedded
tissue was used for extraction of DNA, and performed
as described by Cool et al.2 To detect HHV-8 DNA two
nested PCR reactions were performed to amplify part
of ORF 65 and ORF 73, as described by Goudsmit et al.9
Positive controls (paraffin embedded Kaposi Sarcoma skin)
and negative controls were included in each reaction set. By
a homemade chemokine receptor CCR5 PCR on each
extracted DNA the presence of PCR inhibitors was ruled
out. The assay detection level for HHV-8 was five copies. The
study was approved by the medical ethics committee
of the UMCG, and informed consent was obtained from all
patients.Results
Hematoxylin-eosin staining revealed that characteristic
pathological arteriolar abnormalities were present in all
biopsy specimen. Moreover, plexiform lesions were identi-
fied in 11 out of 13 iPAH, and in six out 14 non-iPAH biopsy
specimen, respectively. In none of the iPAH patients and
none of the non-idiopathic PAH, LANA-1 expression was
demonstrated, whereas LANA-1 was demonstrated in all KS
samples. In addition, PCR amplification failed to detect HHV-
8 DNA in all samples studied, whereas it was positive in all KS
control samples. The control gene CCR5 was detected in all
samples.Discussion
In the present study, using identical methods as described by
Cool et al.2 that is immunohistochemical staining for LANA-1
and HHV-8 DNA amplification by PCR, we failed to detect
HHV-8 in lung tissue from 13 Dutch caukasian patients with
iPAH or 14 patients with non-idiopathic PAH.
Previously, two studies performed in Japanese patients7,8
also failed to confirm the observations by Cool and
coworkers. This difference, however, could be explained
by possible differences in the etiology of iPAH in patients
with a different ethnic background. The patients studied
here, however, all had a Caucasian background, ruling out
such racial differences. Recently, also a study in German
iPAH patients was reported.10 In this study, by immunohis-
tochemistry, using a commercial monoclonal antibody
directed against LANA-1, a positive signal reminiscent of
the ‘‘speckled’’ nuclear pattern typical for HHV-8 infected
cells was demonstrated in 16 out of 26 iPAH lung biopsies.
The expression was, however, confined to bronchial and
alveolar epithelial cells. Only in a single case LANA-1
positive mesenchymal cells were demonstrated adjacent
to plexiform lesions. By different PCR assays (based on ORF
26, ORF K6 and ORF 72, respectively), HHV-8 infection could
not be confirmed. Taken together, the present data appear
to put an end to the ongoing debate on the possible
etiological role of HHV-8 in iPAH.
The recent data are also in line with studies on the
seroprevalence of HHV-8 in patients with iPAH as compared
to non-iPAH patients and healthy individuals. In a German
study,3 no difference was found between 49 iPAH patients
and 17 patients with other forms of pulmonary hyperten-
sion. In this respect, using highly specific and sensitive
serological assays, based on both lytic and latent HHV-8
antigens, Laney and coworkers5 found no evidence of HHV-8
infection in any of the 19 iPAH patients studied. In a recent
French study,4 the prevalence of antibodies against HHV-8
was found similar in iPAH patients and healthy blood donors,
as well as in patients with HIV infection with or without
associated PAH.
How to explain the differences between the initial
observation by Cool and coworkers and all the subsequent
studies? As shown,10 immunochemistry may be prone to
false-positive signals. The specificity of the PCR amplifica-
tion products generated by the primers used by Cool and
coworkers was questioned by Laney and coworkers.7 Indeed,
one round (35 cycles) of PCR may be prone to false positive
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assays,10 or a nested PCR, like we did. A nested PCR
increases the specificity by a second round of amplification
with two HHV-8 specific primers. Moreover, we also used two
different PCR assays to detect HHV-8 DNA based on
sequences of ORF 65 and ORF 73.
In conclusion, the results of the recent studies, in which
no evidence for HHV-8 infection was found in Caucasian iPAH
patients, argue strongly against an etiological role for HHV-8
in the pathogenesis of iPAH. In our view, iPAH can be added
to the list of disorders that in the end were not proven to be
causally linked with HHV-8 infection.
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